Loading insider details...
Beta
Latest Form 4 (Jun 30, 2026): Exercise/Conversion of 7,732 GALT shares, $9.5K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 30, 2026 | GALECTIN THERAPEUTICS INC (GALT) | Exercise/Conversion | 7,732 | $9.5K |
| Jan 21, 2026 | GALECTIN THERAPEUTICS INC (GALT) | Grant/Award | 60,000 | n/a |
| Dec 19, 2025 | GALECTIN THERAPEUTICS INC (GALT) | Exercise/Conversion | 20,000 | $39.6K |
| Dec 16, 2025 | GALECTIN THERAPEUTICS INC (GALT) | Exercise/Conversion | 19,793 | $82.3K |
| Dec 10, 2025 | GALECTIN THERAPEUTICS INC (GALT) | Sale | 4,000 | $24.0K |
| Jan 30, 2025 | GALECTIN THERAPEUTICS INC (GALT) | Grant/Award | 60,000 | n/a |
| Dec 31, 2024 | GALECTIN THERAPEUTICS INC (GALT) | Purchase | 6,500 | $7.5K |
| Jan 30, 2023 | GALECTIN THERAPEUTICS INC (GALT) | Grant/Award | 40,000 | n/a |
| Jan 25, 2022 | GALECTIN THERAPEUTICS INC (GALT) | Grant/Award | 40,000 | n/a |
| Mar 29, 2021 | GALECTIN THERAPEUTICS INC (GALT) | Grant/Award | 40,000 | n/a |